146 related articles for article (PubMed ID: 34636744)
1. Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study.
Le Bras M; Leclerc H; Rousseau O; Goudet P; Cuny T; Castinetti F; Bauters C; Chanson P; Tabarin A; Gaujoux S; Christin-Maitre S; Ruszniewski P; Borson-Chazot F; Guilhem I; Caron P; Goichot B; Beckers A; Delemer B; Raingeard I; Vergès B; Smati S; Wargny M; Cariou B; Hadjadj S
Eur J Endocrinol; 2021 Nov; 185(6):863-873. PubMed ID: 34636744
[TBL] [Abstract][Full Text] [Related]
2. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG).
de Laat JM; Dekkers OM; Pieterman CR; Kluijfhout WP; Hermus AR; Pereira AM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; de Herder WW; Valk GD
J Clin Endocrinol Metab; 2015 Sep; 100(9):3288-96. PubMed ID: 26126205
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
[TBL] [Abstract][Full Text] [Related]
6. Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
Lin KY; Kuo YT; Cheng MF; Chen PL; Wang HP; Cheng TY; Chang CH; Kao HF; Yang SH; Li HY; Lin CH; Chou YT; Chung AK; Wu WC; Lu JY; Wang CY; Hsih WH; Wen CY; Yang WS; Shih SR
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1532-e1541. PubMed ID: 37390813
[TBL] [Abstract][Full Text] [Related]
7. Cushing's syndrome in multiple endocrine neoplasia type 1.
Simonds WF; Varghese S; Marx SJ; Nieman LK
Clin Endocrinol (Oxf); 2012 Mar; 76(3):379-86. PubMed ID: 21916912
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
10. Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
Yarman S; Tuncer FN; Serbest E
Pathobiology; 2019; 86(2-3):128-134. PubMed ID: 30630164
[TBL] [Abstract][Full Text] [Related]
11. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study.
Vergès B; Boureille F; Goudet P; Murat A; Beckers A; Sassolas G; Cougard P; Chambe B; Montvernay C; Calender A
J Clin Endocrinol Metab; 2002 Feb; 87(2):457-65. PubMed ID: 11836268
[TBL] [Abstract][Full Text] [Related]
12. Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1.
Rix M; Hertel NT; Nielsen FC; Jacobsen BB; Hoejberg AS; Brixen K; Hangaard J; Kroustrup JP
Eur J Endocrinol; 2004 Dec; 151(6):709-15. PubMed ID: 15588237
[TBL] [Abstract][Full Text] [Related]
13. Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.
Nunes VS; Souza GL; Perone D; Conde SJ; Nogueira CR
Pituitary; 2014 Feb; 17(1):30-7. PubMed ID: 23334809
[TBL] [Abstract][Full Text] [Related]
14. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
15. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
Stratakis CA; Schussheim DH; Freedman SM; Keil MF; Pack SD; Agarwal SK; Skarulis MC; Weil RJ; Lubensky IA; Zhuang Z; Oldfield EH; Marx SJ
J Clin Endocrinol Metab; 2000 Dec; 85(12):4776-80. PubMed ID: 11134142
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
17. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma.
Farrell WE; Azevedo MF; Batista DL; Smith A; Bourdeau I; Horvath A; Boguszewski M; Quezado M; Stratakis CA
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1905-14. PubMed ID: 21917868
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
[TBL] [Abstract][Full Text] [Related]
19. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N
Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia.
Harding B; Lemos MC; Reed AA; Walls GV; Jeyabalan J; Bowl MR; Tateossian H; Sullivan N; Hough T; Fraser WD; Ansorge O; Cheeseman MT; Thakker RV
Endocr Relat Cancer; 2009 Dec; 16(4):1313-27. PubMed ID: 19620250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
